Takeda Pharmaceutical Company Limited company logo
Takeda Pharmaceutical Company Limited logo

Takeda Pharmaceutical Company Limited (TAK)

Summary

Current Price
As of today, TAK price is $17.63, up +1.38% on
Current Price All-Time High
TAK price is currently -43.66% below its historical high of $31.29 set on
Market Cap
TAK current market cap is $56B, up +21.77% over the past 365 days
Revenue
TAK current annual revenue is $29.90B, down -0.51% year-over-year
Next Earnings
The next earnings release for TAK is on

Profile

Company profile for Takeda Pharmaceutical Company Limited (TAK)
MetricValue
Full NameTakeda Pharmaceutical Company Limited
TickerNYSE: TAK
ExchangeNYSE
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryJapan
IPO
IndexesNot included
Websitetakeda.com
Employees47,455

Key Metrics

Takeda Pharmaceutical Company Limited Key Details
MetricValueDate
Price$17.63
Price, 1D Change+1.38%
Market Cap$56B
TTM Dividend Yield3.58%
PE Ratio-
Beta0.19
Revenue$29.90B
Revenue, 1Y Change-0.51%
EPS-$0.32
EPS, 1Y Change-245.58%

Chart

SUGGESTED SERIES
Takeda Pharmaceutical Company Limited chart

Events

Takeda Pharmaceutical Company Limited Events
MetricValueDate
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.31
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeTKPYY
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

TAK Estimates
MetricValueDate
EPS-$0.32
EPS Estimate-N/A
EPS Est. Change-N/A
Revenue$29.90B
Revenue Estimate-N/A
Revenue Est. Change-N/A
Current Price$17.63
Price Target--
Price Tgt. Change--

🔒 Log In To Unlock Full Data

EPS

TAK EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$0.32-
-$0.22-
--$0.32-
TAK EPS reported versus estimate values chart

Revenue

TAK revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
-$29.49B-
-$30.05B-
-$29.90B-
TAK revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

TAK Performance
MetricValueDate
Price, 1Y+19.12%
Price, 3Y+15.46%
Market Cap, 1Y+21.77%
Market Cap, 3Y+18.59%
Revenue, 1Y-0.51%
Revenue, 3Y+0.61%
EPS, 1Y-245.58%
EPS, 3Y-143.08%

🔒 Log In To Unlock Full Data

Technicals

TAK Technical Indicators
MetricValueDate
Current Price$17.63
SMA 200$16.43
SMA 50$16.54
EMA 200$16.40
EMA 50$16.85
MACD$0.23
Beta0.19
ATR$0.32
14-Day RSI61.44
10-Day Volatility21.78%

Dividends

TAK Dividends
MetricValueDate
Last Paid$0.31
UpcomingN/AN/A
Dividend Yield3.58%
Total Dividend$0.63
$2.07B
-205.03%

🔒 Log In To Unlock Full Data

Income & Profitability

TAK Income & Profitability
MetricValueDate
Revenue$29.90B
EPS-$0.32
Gross Profit$15.27B
Gross Margin51.06%
Operating Income$3.59B
Operating Margin11.99%
Net Income-$1.01B
Net Margin4.26%
EBITDA$8.37B

🔒 Log In To Unlock Full Data

Financial Health

TAK Financial Health
MetricValueDate
Debt To Equity0.63
1.27
0.70
-
4
1.24

Valuations

TAK Valuations
MetricValueDate
PE Ratio-
1.88
1.21
9.05
-N/A

Balance Sheet

TAK Balance Sheet
MetricValueDate
Book Value$48.86B
$3.74B
$97.50B
$19.43B
$50.79B
$15.27B
Total Debt$30.69B
$3.22B
$3.09B

Expenses

TAK Expenses
MetricValueDate
$28.63B
$11.68B
$14.63B
$0.00
$4.79B
$0.00
$452.33M

Cash Flow

TAK Cash Flow
MetricValueDate
$6.23B
-$2.57B
-$2.49B
Capex$2.73B
$3.50B

Recent analyst updates

TAK Recent analyst updates
MetricValueDate
TD Cowen
TD Cowen
B of A Securities
Cowen & Co.
Morgan Stanley
JP Morgan
Cowen & Co.
Jefferies

Analyst sentiment

Sentiment over the past month
TAK analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
TAK institutional ownership distribution chart

Screeners with TAK

FAQ

What is the ticker symbol for Takeda Pharmaceutical Company Limited?
The ticker symbol for Takeda Pharmaceutical Company Limited is NYSE:TAK
Does Takeda Pharmaceutical Company Limited pay dividends?
Yes, Takeda Pharmaceutical Company Limited pays dividends. The last payment was $0.31, with an ex-dividend date on March 31, 2026
What sector is Takeda Pharmaceutical Company Limited in?
Takeda Pharmaceutical Company Limited is in the Healthcare sector
What industry is Takeda Pharmaceutical Company Limited in?
Takeda Pharmaceutical Company Limited is in the Specialty & Generic Drug Manufacturers industry
What country is Takeda Pharmaceutical Company Limited based in?
Takeda Pharmaceutical Company Limited is headquartered in Japan
When did Takeda Pharmaceutical Company Limited go public?
Takeda Pharmaceutical Company Limited initial public offering (IPO) was on January 5, 2010
Is Takeda Pharmaceutical Company Limited in the S&P 500?
No, Takeda Pharmaceutical Company Limited is not included in the S&P 500 index
Is Takeda Pharmaceutical Company Limited in the NASDAQ 100?
No, Takeda Pharmaceutical Company Limited is not included in the NASDAQ 100 index
Is Takeda Pharmaceutical Company Limited in the Dow Jones?
No, Takeda Pharmaceutical Company Limited is not included in the Dow Jones index
When was Takeda Pharmaceutical Company Limited last earnings report?
Takeda Pharmaceutical Company Limited's most recent earnings report was on July 30, 2026
When does Takeda Pharmaceutical Company Limited report earnings?
The next expected earnings date for Takeda Pharmaceutical Company Limited is October 29, 2026

Data Sources & References

  1. TAK Official Website www.takeda.com
  2. TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
  3. TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak